AI news illustration: OpenAI Backs Merge Labs in Quest for Advanced Brain-Computer Interfaces
OpenAI Backs Merge Labs in Brain-Computer Interface Race
Sam Altman has decided to buy a ticket for Elon Musk’s favorite race. OpenAI is now backing Merge Labs, a startup trying to build brain-computer interfaces. The aim is to connect human and artificial intelligence, to move past reading thoughts and into expanding what people can do.
This puts Altman’s money directly opposite Musk’s Neuralink, which has raised $650 million at a $9 billion valuation to help paralyzed patients control devices with their minds. Merge Labs says its approach is different. It wants to integrate biology, hardware, and AI.
For OpenAI, the AI is the core tool, meant to drive research in neuroscience, bioengineering, and device engineering. The mission is huge. The competition is now set.
On BCI, Merge Labs is working to safely interface with the brain at higher bandwidth by integrating biology, hardware devices, and AI. The company's stated long-term mission is to bridge biological and artificial intelligence to expand human capability and agency. The investment puts OpenAI CEO Sam Altman on a collision course with Elon Musk, whose startup Neuralink is working on brain-computer interface chips that enable people with severe paralysis to control devices using their thoughts.
Last year, it secured $650 million in funding at a $9 billion valuation from investors including Sequoia Capital, Thrive Capital, and Vy Capital. According to OpenAI, AI will be central to Merge Labs' work, supporting research across bioengineering, neuroscience, and device engineering.
The check from OpenAI is a flag planted. It says the next big arena for artificial intelligence isn't another chatbot. It's the brain itself.
Altman picking a fight with Neuralink means two of tech’s most stubborn billionaires are betting the same way. They believe the real leverage comes from wiring silicon directly into our biology. The potential is obvious.
A person who can’t move a limb could control a computer. The questions are harder. We do not know how to safely talk to neurons at high speed for decades.
We do not know what “expanding human agency” actually looks like when a corporation is selling the upgrade. Merge Labs has OpenAI’s backing and its AI models. What it needs is a way through a thicket of scientific and ethical problems that no amount of funding can simply clear.
Related Reading
Browse all OpenAI news →
Business & Startups Nordic pilot adds Gemini for Education, NotebookLM to boost AI literacy
Business & Startups Kling launches Video O1, all-in-one model with MVL bridge using transformer
Business & Startups DeepSeek Seeks More Capital Weeks After USD 7B Funding Round
Related Topic OpenAI researcher quits, citing distrust over ad‑driven engagement metrics
LLMs & Generative AI
Related Topic OpenAI launches GPT-Image 1.5 with precise editing for enterprise visuals
LLMs & Generative AI
From Archives Mom of Elon Musk's Child Sues xAI Over Alleged Deepfake Harassment
From Archives MongoDB Bets on Smart Retrieval Over Model Size for Enterprise AI Reliability
From Archives OpenAI Safety Lead Moves to Anthropic's AI Risk Research Team
Research & Benchmarks
From Archives OpenAI Empowers Nonprofits with Tailored AI Solutions in Bengaluru Workshop
Common Questions Answered
How much funding has Merge Labs received so far?
Merge Labs has attracted $252 million in seed funding, which has valued the startup at $850 million. This significant investment indicates serious industry interest in brain-computer interface technologies.
What is Merge Labs' long-term mission for brain-computer interface technology?
Merge Labs aims to bridge biological and artificial intelligence to expand human capability and agency. Their goal is to safely interface with the brain at higher bandwidth by integrating biology, hardware devices, and AI.
How does OpenAI's investment in Merge Labs relate to the broader AI and neurotechnology landscape?
OpenAI's investment signals a strategic interest in technologies that could fundamentally reshape human-machine interaction. By backing Merge Labs, the company is positioning itself at the intersection of neuroscience, hardware engineering, and artificial intelligence.
